07:00 , Oct 12, 2015 |  BC Week In Review  |  Financial News

Exonate completes venture financing

Exonate Ltd. , Cambridge, U.K.   Business: Cancer   Date completed: 2015-10-05   Type: Venture financing   Raised: Not disclosed   Investor: Angel CoFund   Note: Exonate raised an undisclosed amount in a second financing...
07:00 , Oct 12, 2015 |  BioCentury  |  Emerging Company Profile

Balancing VEGF

Exonate Ltd. is developing small molecule inhibitors of SRPK1 to restore the balance of pro- and anti-angiogenic VEGF isoforms in angiogenesis-mediated diseases, with an initial focus on ophthalmologic indications. The company's eye drop formulations of...
07:00 , Aug 11, 2014 |  BC Week In Review  |  Financial News

Destiny Pharma completes venture financing

Destiny Pharma Ltd. , Falmer, U.K.   Business: Infectious   Date completed: 2014-08-04   Type: Venture financing   Raised: L2.8 million ($4.7 million)   Investors: Angel CoFund; and other investors   Note: The company said...
08:00 , Nov 25, 2013 |  BC Week In Review  |  Financial News

Eagle Genomics financial update

Eagle Genomics raised £410,000 ($661,822) in the second close of a venture round, bringing the total raised in the round to £1 million ($1.6 million). The second close was led by existing investor London Business...